The Influence of Laser Crossectomy With Different Wavelengths on Varicose Vein Progression
LACROSS-VVP
1 other identifier
interventional
400
1 country
1
Brief Summary
Technically successful laser crossectomy will reduce the risk of reflux recurrence at the sapheno-femoral junction without increasing the risk of endovenous heat-induced thrombosis, which may positively impact the likelihood of ultrasound- or clinical-recurrence of varicose veins. Similar technical efficacy is expected for laser crossectomy at 1940 nm and 1470 nm. A possible advantage of the 1940 nm wavelength in terms of postoperative pain intensity and the risk of adverse events cannot be ruled out.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 20, 2026
CompletedFirst Submitted
Initial submission to the registry
February 26, 2026
CompletedFirst Posted
Study publicly available on registry
March 4, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 20, 2029
March 4, 2026
February 1, 2026
2 years
February 26, 2026
February 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of patients with reflux recurrence at the sapheno-femoral junction
Defined as the presence of reflux, with a duration of \>0.5 sec under provocation manoeuvre (Valsalva manoeuvre and/or manual distal compression), at the zone of treated SFJ, including reflux on recanalized GSV trunk, on the AASV or any other tributaries, on the lymph node venous network, on the inguinal or perineal veins as detected by duplex ultrasound scan (DUS).
12 months
Secondary Outcomes (9)
Number of patients with technically possible laser crossectomy
0 days
Number of patients with technically successful laser crossectomy
3 days
Length of GSV stump
12 months
Number of patients with EHIT of 2-4 classes
12 months
Number of patients with GSV recanalization
12 months
- +4 more secondary outcomes
Study Arms (3)
Group 1 (1470 nm)
EXPERIMENTALLaser crossectomy will be performed with a wavelength of 1470 nm and radial fiber with a core diameter of 0.4 mm and a bulb diameter of 1.57 mm at a power of 6-8 W by manual extraction at a speed of 1 mm/s (LED of 60-80 J/cm). EVLT of the great saphenous vein (GSV) trunk will be performed with a standard approach.
Group 2 (1940 nm)
EXPERIMENTALLaser crossectomy will be performed with a wavelength of 1940 nm and radial fiber with a core diameter of 0.55 mm and a bulb diameter of 1.4 mm at a power of 4-6 W by manual extraction at a speed of 1 mm/s (LED of 40-60 J/cm). EVLT of the GSV trunk will be performed with a standard approach.
Control
ACTIVE COMPARATORWill contain patients who have failed to perform laser crossectomy at 1470 nm or 1940 nm wavelength due to technical impossibility or technical failure, and underwent EVLT of the GSV trunk with preservation of the stump.
Interventions
Attempt to perform laser crossectomy with radial fiber (core of 0.4 mm, bulb of 1.57 mm) on the 1470 nm wavelength laser with a power of 6-8 W and an LED of 60-80 J/cm. Performing the GSV trunk ablation according to the indications.
Attempt to perform laser crossectomy with radial fiber (core of 0.55 mm, bulb of 1.4 mm) on the 1940 nm wavelength laser with a power of 4-6 W and an LED of 40-60 J/cm. Performing the GSV trunk ablation according to the indications.
Attempted laser crossectomy on 1470 nm or 1940 nm failed due to anatomical features of the SFJ or technical reasons, and the GSV trunk was obliterated with persistence of the stump.
Eligibility Criteria
You may qualify if:
- Age \>18 years
- Primary VVs of Clinical Etiology Anatomy Pathophysiology (CEAP) clinical class of C2-C6
- Reflux along the GSV trunk lasting \>0.5 sec.
- GSV trunk diameter ≤12 mm
- Informed consent to participate in the study
You may not qualify if:
- Primary reflux outside the GSV trunk (including combined reflux)
- History of deep or superficial vein thrombosis
- Deep vein reflux
- Non-thrombotic or post-thrombotic venous obstruction
- Pelvic venous insufficiency
- Use of oral anticoagulants
- Indication for pharmacological prophylaxis after EVLT
- Inability to use radial fiber of 1.4-1.57 mm at the surgeon's discretion
- Refusal to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MedSwiss Private Cinic
Moscow, 143082, Russia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kirill Lobastov, PhD
Pirogov Russian National Research Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of the Department of General surgery named after V.M. Buyanov
Study Record Dates
First Submitted
February 26, 2026
First Posted
March 4, 2026
Study Start
January 20, 2026
Primary Completion (Estimated)
January 20, 2028
Study Completion (Estimated)
January 20, 2029
Last Updated
March 4, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share